The Chinese voice AI company reported strong debut annual performance with substantial second-half loss reduction approaching profitability.
Abivax is advancing obefazimod, a first-in-class oral therapy for UC and CD, with major upcoming data catalysts. Click here ...
Spyre Therapeutics, Inc. earns a Strong Buy on Phase 1 wins, IBD/RA pipeline catalysts, and $757M cash runway. Click for this ...
NASA said Friday it’s revamping its Artemis moon exploration program to make it more like the fast-paced Apollo program half a century ago, adding an extra practice flight before attempting a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results